Pingqing He
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 11, 2020
MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cells.
Journal: Oncotarget
Published: December 06, 2016
Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.
Journal: Science China. Life sciences
Published: November 29, 2016
Bone Morphogenetic Protein-7 Inhibits EMT-Associated Genes in Breast Cancer.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: April 27, 2015
Down-regulation of CEACAM1 in breast cancer.
Journal: Acta biochimica et biophysica Sinica
Published: March 25, 2015
Hyaluroan-regulated lymphatic permeability through S1P receptors is crucial for cancer metastasis.
Journal: Medical oncology (Northwood, London, England)
Published: November 14, 2014
Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway.
Journal: Medical oncology (Northwood, London, England)
Published: November 09, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026